Acrotech Biopharma
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Phone Number
(866) 850-2876Website
www.evomela.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Acrotech Biopharma
Acrotech Biopharma, LLC specializes in the development of pharmaceutical products, notably EVOMELA, which is used as a high-dose conditioning treatment for patients with multiple myeloma prior to stem cell transplantation. The product is known for its propylene glycol-free formulation and stability, providing effective myeloablative conditioning. EVOMELA is designed for patients undergoing autologous stem cell transplantation and is monitored closely for potential severe adverse effects, including bone marrow suppression and hypersensitivity reactions. The company aims to support healthcare professionals in managing multiple myeloma treatment through the provision of effective and safe therapeutic options.Explore more
Popular SearchesAcrotech Biopharma LLC IncEVOMELA.comSpectrum Pharmaceuticals IncSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Acrotech Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Acrotech Biopharma has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Acrotech Biopharma launches new products
Click to see if Acrotech Biopharma had a recent Job posting/layoffs
Earning: See what the market has to say on Acrotech Biopharma recently announced quarterly report
Check out if Acrotech Biopharma is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Acrotech Biopharma
Funding: Get notified immidiatlly once Acrotech Biopharma has new funding data
Website visits: Recent activity has been detected on your website
Acrotech Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Acrotech Biopharma
Find 2 more new buyers
Compare Similar Companies to Acrotech Biopharma
Compare insights from companies similar to Acrotech Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Acrotech Biopharma
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Acrotech Biopharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Acrotech Biopharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Acrotech Biopharma.
Acrotech Biopharma Tech Stack
A closer look at the technologies used by Acrotech Biopharma
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Acrotech Biopharma
Sign Up For FreeTo access detailed company insights
Acrotech Biopharma, LLC specializes in the development of pharmaceutical products, notably EVOMELA, which is used as a high-dose conditioning treatment for patients with multiple myeloma prior to stem cell transplantation. The product is known for its propylene glycol-free formulation and stability, providing effective myeloablative conditioning. E... Read More
